Profile
Jennifer Lagoutte-Renosi is a pharmacist, holds a PhD in science, and is an Associate Professor and Hospital Practitioner in clinical pharmacology and toxicology. Her research investigates the membranotropic effects of drugs, particularly antiplatelet agents, and their interactions with lipid membranes through in silico and in vitro approaches. In clinical pharmacology, she works on therapeutic drug monitoring for antiretroviral treatments and HIV, as well as cohort research and artificial intelligence. She also contributes to ANRS-MIE-supported projects and innovation in pharmacology education.
Education and experience
Jennifer Lagoutte-Renosi is a pharmacist and holds a PhD in science. She is an Associate Professor and Hospital Practitioner in Clinical Pharmacology and Toxicology at Université Marie et Louis Pasteur and Besançon University Hospital, and a member of the SINERGIES laboratory.
Research and teaching
She teaches pharmacology to health-sciences students, including the PASS UE6 module, Master’s-level research pharmacology and pharmacovigilance, and fundamental pharmacology. Her research includes the OCTAVIA HIV project, the ANRS-MIE CARLAPOP project and the PHARMACOL-IA educational project developed with Université Claude Bernard Lyon 1.
Current project
OCTAVIA; ANRS-MIE CARLAPOP; and PHARMACOL-IA, an artificial-intelligence project for pharmacology education.
Areas of expertise
- Membranotropic drugs
- Lipid membranes
- Cardiovascular pharmacology
- Therapeutic drug monitoring
- Antiretroviral treatments
- Artificial intelligence
- Education
- Team
- Team 1 “Integrated and Personalised Care”
- Position
- Associate Professor and Hospital Practitioner in Pharmacology
Professional links
Research affiliations
Publications
Publications are matched automatically using the author’s name.
Nanodomains enriched in arachidonic acid promote P2Y12 receptor oligomerization in the platelet plasma membrane
Allemand, Florentin, Yesylevskyy, Semen, Lagoutte-Renosi, Jennifer, Davani, Siamak, Ramseyer, Christophe
Ticagrelor increases its own potency at the P2Y12 receptor by directly changing the plasma membrane lipid order in platelets
Pyrshev, Kyrylo, Allemand, Florentin, Rabani, Vahideh, Yesylevskyy, Semen, Davani, Siamak, Ramseyer, Christophe, Lagoutte-Renosi, Jennifer
Management of a drug-drug interaction between BRAF inhibitors and combined antiretroviral therapy in a HIV-infected patient with craniopharyngioma
Lagoutte-Renosi, Jennifer, Karsenty, Judith, Martha, Benoit, Davani, Siamak, Muret, Patrice
Molecular modeling in cardiovascular pharmacology: Current state of the art and perspectives
Lagoutte-Renosi, Jennifer, Allemand, Florentin, Ramseyer, Christophe, Yesylevskyy, Semen, Davani, Siamak
β-lactam dosing at the early phase of sepsis: Performance of a pragmatic protocol for target concentration achievement in a prospective cohort study
Winiszewski, Hadrien, Despres, Cyrielle, Puyraveau, Marc, Lagoutte-Renosi, Jennifer, Montange, Damien, Besch, Guillaume, Floury, Sebastien Pili, Chaignat, Claire, Labro, Guylaine, Vettoretti, Lucie, Clairet, Anne-Laure, Capellier, Gilles, Vivet, Berengere, Piton, Gael
Bictegravir/emtricitabine/tenofovir alafenamide combination in the management of kidney transplant patients with HIV receiving immunosuppressants
Lagoutte-Renosi, Jennifer, Flammang, Mylene, Ducloux, Didier, Bamoulid, Jamal, Royer, Pierre-Yves, Lepiller, Quentin, Clairet, Anne-Laure, Davani, Siamak, Muret, Patrice
Validation of an HPLC-MS/MS Method for the Determination of Plasma Ticagrelor and Its Active Metabolite Useful for Research and Clinical Practice
Lagoutte-Renosi, Jennifer, Royer, Bernard, Rabani, Vahideh, Davani, Siamak
Real-Life Impact on Lipid Profile of a Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected Patients
Lagoutte-Renosi, Jennifer, Flammang, Mylene, Chirouze, Catherine, Beck-Wirth, Genevieve, Bozon, Fabienne, Brunel, Anne-Sophie, Drobacheff-Thiebaut, Marie-Christine, Foltzer, Adeline, Hustache-Mathieu, Laurent, Kowalczyk, Jakub, Michel, Catherine, Davani, Siamak, Muret, Patrice
Influence of Antiplatelet Agents on the Lipid Composition of Platelet Plasma Membrane: A Lipidomics Approach with Ticagrelor and Its Active Metabolite
Lagoutte-Renosi, Jennifer, Allemand, Florentin, Ramseyer, Christophe, Rabani, Vahideh, Davani, Siamak
Cholesterol-Rich Microdomains Contribute to PAR1 Signaling in Platelets Despite a Weak Localization of the Receptor in These Microdomains
Rabani, Vahideh, Lagoutte-Renosi, Jennifer, Series, Jennifer, Valot, Benoit, Xuereb, Jean-Marie, Davani, Siamak
The pharmacokinetic challenge of treating invasive aspergillosis complicating severe influenzae assisted by extracorporeal membrane oxygenation
Winiszewski, Hadrien, Rougny, Anne-Claire, Lagoutte-Renosi, Jennifer, Millon, Laurence, Capellier, Gilles, Navellou, Jean-Christophe, Piton, Gael, Clairet, Anne-Laure
A simple and fast HPLC-MS/MS method for simultaneous determination of direct oral anticoagulants apixaban, dabigatran, rivaroxaban in human plasma
Lagoutte-Renosi, Jennifer, Le Poupon, Julien, Girard, Alexandra, Montange, Damien, Davani, Siamak